---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-030963"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:32:56.426952+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Syra Health Q2 revenue $2.0M (+101% YoY); net loss widens to $1.4M

## Summary
- Revenue $2.0M vs $1.0M in Q2 2023; Population Health grew 276% YoY, Healthcare Workforce 66%.
- Gross margin improved to 17.8% from 13.1% on mix shift toward higher-margin population health.
- Net loss of $1.4M compared to $802.8K loss in Q2 2023; Adjusted EBITDA -$1.3M vs -$771K.
- Cash $1.6M and no long-term debt; 25% reduction in executive pay implemented starting Q3 2024.
- Subcontractor on $43B DHA workforce contract vehicle; $5.8M Indiana health education contract.

## SEC filing metadata
- accession: 0001493152-24-030963
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000149315224030963/0001493152-24-030963-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000149315224030963/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-030963
- JSON: https://secwatch.observer/filing/0001493152-24-030963.json
- Plain text: https://secwatch.observer/filing/0001493152-24-030963.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.